Cyanotech Corporation (CYAN)
Add to Watchlists Create an AlertCYAN Key Stats
| Income Statement | |
| Revenue TTM | 26.67M |
| Revenue Quarterly YoY Growth | 7.99% |
| EPS Diluted TTM | 0.4746 |
| EPS Diluted Quarterly YoY Growth | -45.00% |
| Net Income TTM | 2.735M |
| Profitability | |
| Gross Profit Margin Quarterly | 39.56% |
| Profit Margin Quarterly | 8.38% |
| Dividend | |
| Dividend Yield | 0.00% |
| Payout Ratio TTM Pro | Go Pro |
| Current Valuation | |
| Market Cap | 31.53M |
| Enterprise Value | 30.27M |
| PE Ratio TTM | 12.16 |
| PE 10 Pro | Go Pro |
| PEG Ratio | |
| Price / Book Value | 1.809 |
| Other | |
| Beta Pro | Go Pro |
| Debt to Equity Ratio | 0.1349 |
| Free Cash Flow | -1.944M |
| Return on Equity | 17.27% |
CYAN News
- Nasdaq stocks posting largest percentage increases May 20
- Emerging Health Food Company With Upside Potential Apr 25
- Hawaiian Telcom Holdco leads Hawaii stocks on mixed day bizjournals.com Mar 21
- Healthcare Sector: High Quality Stocks At A Great Value Mar 18
- Most Hawaii stocks post gains on record day for Wall Street bizjournals.com Mar 14
- Hawaii stocks trend lower, but Dow Jones Industrial Average reaches all-time hig... Mar 12
- Royal Hawaiian Orchards gains but Hawaii stocks close mixed on a good day for Wa... Mar 8
- Most Hawaii stocks post gains as Wall Street begins the week on upward swing bizjournals.com Mar 4
- Cyanotech gains 3% but most Hawaii stocks close lower in Thursday trading bizjournals.com Feb 28
- Stocks Hitting 52-Week Lows Benzinga Feb 27
CYAN Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Cyanotech Corporation is down 24.77% over the last year vs S&P 500 Total Return up 27.09%, KYTHERA Biopharmaceuticals down 0.24%, and Intercept Pharmaceuticals up 0.00%.
CYAN Fundamentals
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Cash Flow Statement View Statement
You may also be interested in these CYAN related companies
Pro Ratings for CYAN
Pro Report PDF for CYAN
Download Pro Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.
Pro Strategies Featuring CYAN
Did Cyanotech Corporation make it into our Pro Portfolio Strategies?
CYAN Profile
Sector: Healthcare
Industry: Drug Manufacturers - Major
Other CYAN Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership MSN Money
- SEC Filings SEC
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| CYAN | 5.77 | -0.07 | -1.20% | 31.53M |